Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice.
Exposure to radiation during fetal development induces testicular germ cell tumors (TGCT) and reduces spermatogenesis in mice. However, whether DNA damaging chemotherapeutic agents elicit these effects in mice remains unclear. Among such agents, cyclophosphamide (CP) is currently used to treat breas...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0093311 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849332468548632576 |
|---|---|
| author | Paul B Comish Ana Luiza Drumond Hazel L Kinnell Richard A Anderson Angabin Matin Marvin L Meistrich Gunapala Shetty |
| author_facet | Paul B Comish Ana Luiza Drumond Hazel L Kinnell Richard A Anderson Angabin Matin Marvin L Meistrich Gunapala Shetty |
| author_sort | Paul B Comish |
| collection | DOAJ |
| description | Exposure to radiation during fetal development induces testicular germ cell tumors (TGCT) and reduces spermatogenesis in mice. However, whether DNA damaging chemotherapeutic agents elicit these effects in mice remains unclear. Among such agents, cyclophosphamide (CP) is currently used to treat breast cancer in pregnant women, and the effects of fetal exposure to this drug manifested in the offspring must be better understood to offer such patients suitable counseling. The present study was designed to determine whether fetal exposure to CP induces testicular cancer and/or gonadal toxicity in 129 and in 129.MOLF congenic (L1) mice. Exposure to CP on embryonic days 10.5 and 11.5 dramatically increased TGCT incidence to 28% in offspring of 129 mice (control value, 2%) and to 80% in the male offspring of L1 (control value 33%). These increases are similar to those observed in both lines of mice by radiation. In utero exposure to CP also significantly reduced testis weights at 4 weeks of age to ∼ 70% of control and induced atrophic seminiferous tubules in ∼ 30% of the testes. When the in utero CP-exposed 129 mice reached adulthood, there were significant reductions in testicular and epididymal sperm counts to 62% and 70%, respectively, of controls. In female offspring, CP caused the loss of 77% of primordial follicles and increased follicle growth activation. The results indicate that i) DNA damage is a common mechanism leading to induction of testicular cancer, ii) increased induction of testis cancer by external agents is proportional to the spontaneous incidence due to inherent genetic susceptibility, and iii) children exposed to radiation or DNA damaging chemotherapeutic agents in utero may have increased risks of developing testis cancer and having reduced spermatogenic potential or diminished reproductive lifespan. |
| format | Article |
| id | doaj-art-46f27dca5a4e46849f8299f3377c0081 |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-46f27dca5a4e46849f8299f3377c00812025-08-20T03:46:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9331110.1371/journal.pone.0093311Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice.Paul B ComishAna Luiza DrumondHazel L KinnellRichard A AndersonAngabin MatinMarvin L MeistrichGunapala ShettyExposure to radiation during fetal development induces testicular germ cell tumors (TGCT) and reduces spermatogenesis in mice. However, whether DNA damaging chemotherapeutic agents elicit these effects in mice remains unclear. Among such agents, cyclophosphamide (CP) is currently used to treat breast cancer in pregnant women, and the effects of fetal exposure to this drug manifested in the offspring must be better understood to offer such patients suitable counseling. The present study was designed to determine whether fetal exposure to CP induces testicular cancer and/or gonadal toxicity in 129 and in 129.MOLF congenic (L1) mice. Exposure to CP on embryonic days 10.5 and 11.5 dramatically increased TGCT incidence to 28% in offspring of 129 mice (control value, 2%) and to 80% in the male offspring of L1 (control value 33%). These increases are similar to those observed in both lines of mice by radiation. In utero exposure to CP also significantly reduced testis weights at 4 weeks of age to ∼ 70% of control and induced atrophic seminiferous tubules in ∼ 30% of the testes. When the in utero CP-exposed 129 mice reached adulthood, there were significant reductions in testicular and epididymal sperm counts to 62% and 70%, respectively, of controls. In female offspring, CP caused the loss of 77% of primordial follicles and increased follicle growth activation. The results indicate that i) DNA damage is a common mechanism leading to induction of testicular cancer, ii) increased induction of testis cancer by external agents is proportional to the spontaneous incidence due to inherent genetic susceptibility, and iii) children exposed to radiation or DNA damaging chemotherapeutic agents in utero may have increased risks of developing testis cancer and having reduced spermatogenic potential or diminished reproductive lifespan.https://doi.org/10.1371/journal.pone.0093311 |
| spellingShingle | Paul B Comish Ana Luiza Drumond Hazel L Kinnell Richard A Anderson Angabin Matin Marvin L Meistrich Gunapala Shetty Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice. PLoS ONE |
| title | Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice. |
| title_full | Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice. |
| title_fullStr | Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice. |
| title_full_unstemmed | Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice. |
| title_short | Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice. |
| title_sort | fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice |
| url | https://doi.org/10.1371/journal.pone.0093311 |
| work_keys_str_mv | AT paulbcomish fetalcyclophosphamideexposureinducestesticularcancerandreducedspermatogenesisandovarianfolliclenumbersinmice AT analuizadrumond fetalcyclophosphamideexposureinducestesticularcancerandreducedspermatogenesisandovarianfolliclenumbersinmice AT hazellkinnell fetalcyclophosphamideexposureinducestesticularcancerandreducedspermatogenesisandovarianfolliclenumbersinmice AT richardaanderson fetalcyclophosphamideexposureinducestesticularcancerandreducedspermatogenesisandovarianfolliclenumbersinmice AT angabinmatin fetalcyclophosphamideexposureinducestesticularcancerandreducedspermatogenesisandovarianfolliclenumbersinmice AT marvinlmeistrich fetalcyclophosphamideexposureinducestesticularcancerandreducedspermatogenesisandovarianfolliclenumbersinmice AT gunapalashetty fetalcyclophosphamideexposureinducestesticularcancerandreducedspermatogenesisandovarianfolliclenumbersinmice |